AI assistant
MEDIFAST INC — Director's Dealing 2020
Jun 8, 2020
33899_dirs_2020-06-08_193888b0-c958-40bc-8189-209380aa9cd5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2020-06-04
Reporting Person: SCHLACKMAN SCOTT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-04 | Common Stock | M | 1500.00 | $27.68 | Acquired | 7555.00 | Direct |
| 2020-06-04 | Common Stock | S | 1619.00 | $107.35 | Disposed | 5936.00 | Direct |
| 2020-06-04 | Common Stock | S | 1500.00 | $107.77 | Disposed | 4436.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-04 | Stock Option (Right to Buy) | $27.68 | M | 1500.00 | Disposed | 2026-02-04 | Common Stock (1500.00) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.28 to $107.46, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $107.79, inclusive.
F3: These stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, vested and became non-forfeitable on each of the first, second and third anniversaries of the Grant Date subject to the requirements of the Plan and Award Agreement beginning on 04-Feb-2016.